PALO ALTO, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), a clinical-stage biotechnology company today released the following
Gainers
OpGen (NASDAQ:OPGN) shares rose 20.6% to $0.52 during Monday's after-market session. This security traded at a volume of 927.4K shares come close, making up 324.6% of its average volume over the last 100 days. The company's market cap stands at $25.0 million.
Gainers
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares surged 78% to $2.2399 as the stock continued to see momentum despite the company last week announcing it is not aware of any developments that would explain the recent surge.
Gainers
Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 31.2% to $0.6931 in pre-market trading as the company presented positive data from ongoing ReSPECT™ clinical trials at the Annual Conference on CNS Clinical Trials and Brain Metastases.
180 Life Sciences Corp. (NASDAQ:ATNF, ", 180 Life Sciences", or the ", Company", )))), a clinical-stage biotechnology company, today announced that it has entered into a definitive agreement with a single
Gainers
United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.